Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis
Open Access
- 11 September 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (20) , 11503-11508
- https://doi.org/10.1073/pnas.181338198
Abstract
Sepsis remains a significant clinical conundrum, and recent clinical trials with anticytokine therapies have produced disappointing results. Animal studies have suggested that increased lymphocyte apoptosis may contribute to sepsis-induced mortality. We report here that inhibition of thymocyte apoptosis by targeted adenovirus-induced thymic expression of human IL-10 reduced blood bacteremia and prevented mortality in sepsis. In contrast, systemic administration of an adenovirus expressing IL-10 was without any protective effect. Improvements in survival were associated with increases in Bcl-2 expression and reductions in caspase-3 activity and thymocyte apoptosis. These studies demonstrate that thymic apoptosis plays a critical role in the pathogenesis of sepsis and identifies a gene therapy approach for its therapeutic intervention.Keywords
This publication has 28 references indexed in Scilit:
- Apoptosis in sepsis: a new target for therapeutic explorationThe FASEB Journal, 2001
- ANIMAL MODELS OF SEPSIS AND SHOCKShock, 1998
- Monocyte deactivation in septic patients: Restoration by IFN-γ treatmentNature Medicine, 1997
- Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2Journal of Biological Chemistry, 1996
- Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in miceNature Medicine, 1996
- Induction of apoptosis in mature T cells by tumour necrosis factorNature, 1995
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995
- Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis SyndromeJAMA, 1994
- Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.Journal of Clinical Investigation, 1994
- bcl-2 transgene inhibits T cell death and perturbs thymic self-censorshipCell, 1991